Led by world-renowned expert Dr. David Chereney, this presentation delves into emerging strategies beyond Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors in Chronic Kidney Disease (CKD) management.


UKidney answers your nephrology questions! Feel free to search our previous submissions or create your own today.
Ask a new question